44 results
424B3
SKYE
Skye Bioscience Inc
10 Apr 24
Prospectus supplement
4:40pm
to achieve our goals, and a failure to obtain this necessary capital when needed on acceptable terms, or at all, could force us to delay, limit … observation period. The main goal is to measure the percentage of weight loss by week 26, with secondary goals assessing changes in waist size, body
8-K
EX-99.3
t0h7xr
21 Aug 23
Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
8:36am
DEFM14A
ydnnyke4cy9 mod5nv
31 Aug 22
Proxy related to merger
5:19pm
PREM14A
jx9oriubq w9h
15 Aug 22
Preliminary proxy related to merger
12:00am
8-K
zsgwxscod lwe1g
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
EX-99.1
0irrh qxss7lig1
12 May 22
Skye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
9:08am
8-K
EX-99.1
11q8h459h 53j4
20 Dec 21
Skye Bioscience Announces Promotion of Tu Diep, MSc to Chief Development Officer
5:25pm
8-K
EX-10.1
47ajv krqggk3xqpi
15 Oct 21
Entry into a Material Definitive Agreement
5:05pm
424B3
hmuby1hmd8jl23rbq0du
2 Mar 21
Prospectus supplement
12:00am
424B4
l05p11 33g
3 Aug 20
Prospectus supplement with pricing info
5:02pm